Literature DB >> 17217852

Translational research in stroke: taking advances in the pathophysiology and treatment of stroke from the experimental setting to clinical trials.

Marc Fisher1, Nils Henninger.   

Abstract

Many advances have occurred regarding an increased understanding of the basic pathophysiology of ischemic brain injury that could lead to enhanced therapy for this disorder. Among the more important basic science advances are enhanced knowledge of the components of the ischemic cascade, the phenomenon of ischemic preconditioning, the potential relevance of hibernation, studies on gene expression in ischemic tissue, and imaging identification of the ischemic penumbra. The large number of unsuccessful prior clinical trials with a wide range of purported acute stroke therapies has provided many insights and lessons regarding how to perform better trials in the future. Translating these basic science and clinical trial design advances into effective and safe therapies will require increased interaction and cooperation between basic scientists and clinical researchers.

Entities:  

Mesh:

Year:  2007        PMID: 17217852     DOI: 10.1007/s11910-007-0019-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  59 in total

Review 1.  Recommendations for clinical trial evaluation of acute stroke therapies.

Authors: 
Journal:  Stroke       Date:  2001-07       Impact factor: 7.914

Review 2.  Present status of magnetic resonance imaging and spectroscopy in animal stroke models.

Authors:  Ralph Weber; Pedro Ramos-Cabrer; Mathias Hoehn
Journal:  J Cereb Blood Flow Metab       Date:  2006-05       Impact factor: 6.200

3.  The cerebral ischemic penumbra.

Authors:  A M Hakim
Journal:  Can J Neurol Sci       Date:  1987-11       Impact factor: 2.104

4.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

5.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

6.  Tolerability of NXY-059 at higher target concentrations in patients with acute stroke.

Authors:  K R Lees; D Barer; G A Ford; W Hacke; V Kostulas; A K Sharma; T Odergren
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

7.  Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.

Authors:  Rainer Kollmar; Nils Henninger; Jürgen Bardutzky; Peter D Schellinger; Wolf-Rüdiger Schäbitz; Stefan Schwab
Journal:  Exp Neurol       Date:  2004-11       Impact factor: 5.330

8.  NXY-059 for acute ischemic stroke.

Authors:  Kennedy R Lees; Justin A Zivin; Tim Ashwood; Antonio Davalos; Stephen M Davis; Hans-Christoph Diener; James Grotta; Patrick Lyden; Ashfaq Shuaib; Hans-Göran Hårdemark; Warren W Wasiewski
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

Review 9.  Models of focal cerebral ischemia in the nonhuman primate.

Authors:  Shunichi Fukuda; Gregory J del Zoppo
Journal:  ILAR J       Date:  2003

Review 10.  Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.

Authors:  David J Gladstone; Sandra E Black; Antoine M Hakim
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

View more
  5 in total

1.  Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro.

Authors:  Brian J Lee; Yasuhiro Egi; Klaus van Leyen; Eng H Lo; Ken Arai
Journal:  Brain Res       Date:  2009-10-17       Impact factor: 3.252

2.  A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.

Authors:  Norio Fujiwara; Angel T Som; Loc-Duyen D Pham; Brian J Lee; Emiri T Mandeville; Eng H Lo; Ken Arai
Journal:  Neurosci Lett       Date:  2016-08-30       Impact factor: 3.046

Review 3.  Nucleic Acid Therapies for Ischemic Stroke.

Authors:  Nils Henninger; Yunis Mayasi
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

4.  The Continued Promise of Neuroprotection for Acute Stroke Treatment.

Authors:  Shimin Liu; Steven R Levine
Journal:  J Exp Stroke Transl Med       Date:  2008

5.  Magnetic resonance characterization of ischemic tissue metabolism.

Authors:  Jerry S Cheung; Xiaoying Wang; Phillip Zhe Sun
Journal:  Open Neuroimag J       Date:  2011-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.